Joseph Dear, chief investment officer at the California Public Employees’ Retirement System (CalPERS), has died. Dear had been battling prostate cancer and last summer stepped back from...
People | 27 Feb 2014 |
California Public Employees’ Retirement System (CalPERS), the largest public pension fund in the US with more than $277 billion in assets, will reduce its target allocation for private equity from 14% to 12%. The move is part of a broader effort to...
LPs | 21 Feb 2014 |
Hong Kong billionaire Li Ka-Shing’s Horizon Ventures has led a $23 million Series B financing round for Hampton Creek, a US-based food technology firm.
Venture | 19 Feb 2014 |
TPG Capital and Fosun Industrial have teamed up with the CEO of Chinese healthcare provider Chindex International have won board approval to privatize the NASDAQ-listed company. The deal values Chindex at approximately $369 million.
Buyouts | 18 Feb 2014 |
Japanese incubator Digital Garage (DG) has invested $10 million in Betaworks, a New York-based early-stage tech investor. DG contributed $7.5 million to the round with the balance coming from a group of angel investors.
North Asia | 17 Feb 2014 |
Sungy Mobile, a VC-backed Chinese app developer that went public on NASDAQ last year, has acquired GetJar, a US-based mobile ad network. GetJar previously raised three rounds of VC funding, two led by Accel Partners and the third led by Tiger Global....
Technology | 13 Feb 2014 |
Eleven Biotherapeutics, a US biopharma company firm backed by Japan’s Jafco Ventures, has raised $50 million through its NASDAQ IPO – short of the $69 million initially sought.
Venture | 12 Feb 2014 |
A legal ruling might ban the Big Four accounting firms’ China affiliates from working on US-listed Chinese companies. VCs aren’t worried about IPO prospects, but there are longer-term concerns
Advisory | 12 Feb 2014 |
Infinity Group, the Israel-based PE firm created by China Development Bank and local conglomerate IDB Group, has teamed up with oil technology firm Glori Energy to acquire oil-producing assets in Texas from Petro-Hunt for $40 million.
Greater China | 07 Feb 2014 |
Envision Pharma Group, a scientific communication company backed by US-based private equity firm The Halifax Group, has acquired Australian medical writing firm ProSribe in a move to expand its Asian footprint.
Australasia | 06 Feb 2014 |
Legend Capital has re-upped in athlete training technology developer Zepp Labs, participating in a $15 million Series B round of funding led by GGV Capital. Bertelsmann and Cherubic Ventures also committed capital.
Venture | 27 Jan 2014 |
A US judge has ruled that the China-based units of the Big Four global accounting firms should be suspended from auditing US-listed companies for the next six months. They are accused of failing to disclose information to US regulators investigating Chinese...
Regulation | 24 Jan 2014 |
Wakabayashi Fund, a private equity firm based in Tokyo and New York, has invested in US healthcare firm MIT Holdings. The financial details of the transaction were not disclosed.
Healthcare | 17 Jan 2014 |
Amaranth Medical, a medical device manufacturer backed by Singapore’s Bio*One Capital and Phillip Private Equity, has received a Series C round of funding from US-listed Boston Scientific.
Venture | 15 Jan 2014 |
Apollo Global Management has held a final close on its flagship global fund - Apollo Investment Fund VIII - at $18.4 billion, the largest of its kind since the global financial crisis.
Fundraising | 10 Jan 2014 |
Updating your subscription status
Join us at the 11th Annual AVCJ Private Equity & Venture Australia and New Zealand Forum on 5-7 March at the Four Seasons Hotel in Sydney to find out how funds of varying size are raising capital, sourcing deals and exits, as well as all you need to know to effectively navigate Australasia's changing alternative asset landscape.
After a decade-long mining boom the economy is experiencing a loss of momentum and the resulting deal flow reduction and lack of value in the market means GPs are chasing many of the same acquisition targets. That said, the exit market is recovering with both IPOs and M&A activity picking up, and an increase in LPs appetite for the asset class, and the recent government change means that the industry is cautiously optimistic for the future and expecting a rise in activity over the next 12 months.
5-7 March 2014, Four Seasons Hotel, Sydney